Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.
NCT ID: NCT03175952
Last Updated: 2017-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2017-05-01
2020-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endovascular Aortic Repair for Aortic Dissection
NCT01505309
Prospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital
NCT02667548
China PEACE-Prospective 3-vessel Disease Study
NCT01625312
PEACE Prospective Study of Patients With Three-vessel Disease
NCT01617785
Long-Term Outcomes in Patients With Three-Vessel Disease
NCT05007054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCI
virtual histology intravascular ultrasound
Patients with saphenous vein graft disease will be examined using virtual histology intravascular ultrasound, and treated with percutaneous coronary intervention. Then they will be followed up at 1, 6 and 12 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
virtual histology intravascular ultrasound
Patients with saphenous vein graft disease will be examined using virtual histology intravascular ultrasound, and treated with percutaneous coronary intervention. Then they will be followed up at 1, 6 and 12 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planning to receive PCI using drug-eluting stents
* 18 to 80 years old
* Finishing VH-IVUS examination
* Willing to participate in the study and sign informed consent
Exclusion Criteria
* Aspirin and clopidogrel allergy
* Acute myocardial infarction after CABG
* History of stroke in the past 3 months
* Gastrointestinal bleeding and hemoptysis recently
* Vasculitis and non-atherosclerotic coronary artery disease
* Coagulation disorders
* History of malignancy
* Women during pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin Chest Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yin Liu
director, Cardiology Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yin Liu
Role: PRINCIPAL_INVESTIGATOR
Tianjin Chest Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Liu Y, Wang HB, Li X, Xiao JY, Wang JX, Reilly KH, Sun B, Gao J. Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study. BMC Cardiovasc Disord. 2018 Dec 12;18(1):233. doi: 10.1186/s12872-018-0975-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16YFZCSY00800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.